Physicochemical Properties
| Molecular Formula | C2H2INAO2 |
| Molecular Weight | 207.93 |
| Exact Mass | 207.899 |
| CAS # | 305-53-3 |
| PubChem CID | 5239 |
| Appearance | Solid powder |
| Boiling Point | 262.1ºC at 760mmHg |
| Melting Point | 208 °C (dec.)(lit.) |
| Flash Point | 112.3ºC |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 6 |
| Complexity | 46.8 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(=O)([O-])CI.[Na+] |
| InChi Key | AGDSCTQQXMDDCV-UHFFFAOYSA-M |
| InChi Code | InChI=1S/C2H3IO2.Na/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1 |
| Chemical Name | sodium;2-iodoacetate |
| Synonyms | Iodoacetic acid sodium salt |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Xu, Y. et al. Glycolysis in Innate Immune Cells Contributes to Autoimmunity. Frontiers in Immunology, 13. [2]. Soluble CCR2 gene therapy controls joint inflammation, cartilage damage, and the progression of osteoarthritis by targeting MCP-1 in a monosodium iodoacetate (MIA)-induced OA rat model. Journal of Translational Medicine, 20(1) |
| Additional Infomation | A derivative of ACETIC ACID that contains one IODINE atom attached to its methyl group. |
Solubility Data
| Solubility (In Vitro) |
DMSO : 100 mg/mL (480.93 mM; with sonication) H2O : ≥ 100 mg/mL (480.93 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 100 mg/mL (480.93 mM)(Saturation unknown) in Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution, *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.8093 mL | 24.0466 mL | 48.0931 mL | |
| 5 mM | 0.9619 mL | 4.8093 mL | 9.6186 mL | |
| 10 mM | 0.4809 mL | 2.4047 mL | 4.8093 mL |